A meta-analysis conducted by Breitenstein et al. (34) pooled data from 7 randomized clinical trials (RCTs) (35-41) between January 1998 and October 2007 and concluded that IFNa had a significant beneficial effect on both survival and tumor recurrence. This evidence concerns the gene IFNA1 and neoplasm.